Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Arbez

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 11, 2018
N6-Furfuryladenine is protective in Huntington's disease models by signaling huntingtin phosphorylationLaura E Bowie, Tamara Maiuri, Melanie Alpaugh, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 14, 2021
RNA Toxicity and Perturbation of rRNA Processing in Spinocerebellar Ataxia Type 2Pan P Li, Roumita Moulick, Hongxuan Feng, et al.
Journal of Proteome Research|June 28, 2017
Post-Translational Modifications (PTMs), Identified on Endogenous Huntingtin, Cluster within Proteolytic Domains between HEAT RepeatsTamara Ratovitski, Robert N O'Meally, Mali Jiang, et al.
The EMBO Journal|August 7, 2020
TBK1 phosphorylates mutant Huntingtin and suppresses its aggregation and toxicity in Huntington's disease modelsRamanath Narayana Hegde, Anass Chiki, Lara Petricca, et al.
Human Molecular Genetics|July 23, 2021
Immortalized striatal precursor neurons from Huntington's disease patient-derived iPS cells as a platform for target identification and screening for experimental therapeuticsSergey S Akimov, Mali Jiang, Amanda J Kedaigle, et al.
Human Molecular Genetics|April 4, 2020
Nemo-like kinase reduces mutant huntingtin levels and mitigates Huntington's diseaseMali Jiang, Xiaoyan Zhang, Hongshuai Liu, et al.
Nature Communications|June 9, 2016
Ubiqutination via K27 and K29 chains signals aggregation and neuronal protection of LRRK2 by WSB1Frederick C Nucifora, Leslie G Nucifora, Chee-Hoe Ng, et al.
Science Translational Medicine|December 8, 2017
PPARδ activation by bexarotene promotes neuroprotection by restoring bioenergetic and quality control homeostasisAudrey S Dickey, Dafne N Sanchez, Martin Arreola, et al.
Neuron|April 7, 2017
Mutant Huntingtin Disrupts the Nuclear Pore ComplexJonathan C Grima, J Gavin Daigle, Nicolas Arbez, et al.
Nature Medicine|December 8, 2015
PPAR-δ is repressed in Huntington's disease, is required for normal neuronal function and can be targeted therapeuticallyAudrey S Dickey, Victor V Pineda, Taiji Tsunemi, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|July 11, 2018
N6-Furfuryladenine is protective in Huntington's disease models by signaling huntingtin phosphorylationLaura E Bowie, Tamara Maiuri, Melanie Alpaugh, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 14, 2021
RNA Toxicity and Perturbation of rRNA Processing in Spinocerebellar Ataxia Type 2Pan P Li, Roumita Moulick, Hongxuan Feng, et al.
Journal of Proteome Research|June 28, 2017
Post-Translational Modifications (PTMs), Identified on Endogenous Huntingtin, Cluster within Proteolytic Domains between HEAT RepeatsTamara Ratovitski, Robert N O'Meally, Mali Jiang, et al.
The EMBO Journal|August 7, 2020
TBK1 phosphorylates mutant Huntingtin and suppresses its aggregation and toxicity in Huntington's disease modelsRamanath Narayana Hegde, Anass Chiki, Lara Petricca, et al.
Human Molecular Genetics|July 23, 2021
Immortalized striatal precursor neurons from Huntington's disease patient-derived iPS cells as a platform for target identification and screening for experimental therapeuticsSergey S Akimov, Mali Jiang, Amanda J Kedaigle, et al.
Human Molecular Genetics|April 4, 2020
Nemo-like kinase reduces mutant huntingtin levels and mitigates Huntington's diseaseMali Jiang, Xiaoyan Zhang, Hongshuai Liu, et al.
Nature Communications|June 9, 2016
Ubiqutination via K27 and K29 chains signals aggregation and neuronal protection of LRRK2 by WSB1Frederick C Nucifora, Leslie G Nucifora, Chee-Hoe Ng, et al.
Science Translational Medicine|December 8, 2017
PPARδ activation by bexarotene promotes neuroprotection by restoring bioenergetic and quality control homeostasisAudrey S Dickey, Dafne N Sanchez, Martin Arreola, et al.
Neuron|April 7, 2017
Mutant Huntingtin Disrupts the Nuclear Pore ComplexJonathan C Grima, J Gavin Daigle, Nicolas Arbez, et al.
Nature Medicine|December 8, 2015
PPAR-δ is repressed in Huntington's disease, is required for normal neuronal function and can be targeted therapeuticallyAudrey S Dickey, Victor V Pineda, Taiji Tsunemi, et al.
Pageof 4